NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ:BIOA) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of BioAge investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all shareholders that purchased stock pursuant and/or traceable to BioAge’s registration statement for the initial public offering held on or about September 26, 2024. Follow the link below to get more information and be contacted by a member of our team:
https://zlk.com/pslra-1/bioage-labs-inc-lawsuit-submission-form?prid=132370&wire=3
BIOA investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: According to the …
